AACR 2021: Experimental Vaccine Incorporating Patient-Specific Neoantigen Peptides Shows Promise in Treatment of Malignancies
Proof-of-concept trial demonstrated feasibility, good tolerability, and hints of efficacy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.